<?xml version="1.0" encoding="UTF-8"?>
<p id="Par3">The growing number of infections and deaths resulting from the Coronavirus Disease 2019 (COVID-19) pandemic highlights the need for an accelerated search for effective treatments. Drug repositioning, also known as redirecting, repurposing, and reprofiling, is defined as a different application of the drug than the one that it was initially produced and emerges as an effective and quick possibility to combat COVID-19 (Serafin et al. 
 <xref ref-type="bibr" rid="CR117">2020</xref>). Several drugs already in use have been tested against SARS-CoV-2 and, among them, the majority drugs are antivirals (Sanders et al. 
 <xref ref-type="bibr" rid="CR113">2020</xref>).
</p>
